Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SK08 in active mild to moderate ulcerative colitis
NCT06725017Phase 2Not yet recruiting
- Sponsor
- Zhiyi Pharmaceutics
- Start
- Jul 2025
- Primary completion
- Jul 2027
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 2 trial of SK08 in ulcerative colitis (UC), sponsored by Zhiyi Pharmaceutics. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
SK08
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06725017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06725017.